Literature DB >> 31569279

Double-strand breakage in the extrachromosomal double minutes triggers their aggregation in the nucleus, micronucleation, and morphological transformation.

Yoshihiro Oobatake1, Noriaki Shimizu1.   

Abstract

Gene amplification plays a pivotal role in malignant transformation. Amplified genes often reside on extrachromosomal double minutes (DMs). Low-dose hydroxyurea induces DM aggregation in the nucleus which, in turn, generates micronuclei composed of DMs. Low-dose hydroxyurea also induces random double-strand breakage throughout the nucleus. In the present study, we found that double-strand breakage in DMs is sufficient for induction of DM aggregation. Here, we used CRISPR/Cas9 to introduce specific breakages in both natural and artificially tagged DMs of human colorectal carcinoma COLO 320DM cells. Aggregation occurred in the S phase but not in the G1 phase within 4 hours after breakage, which suggested the possible involvement of homologous recombination in the aggregation of numerous DMs. Simultaneous detection of DMs and the phosphorylated histone H2AX revealed that the aggregation persisted after breakage repair. Thus, the aggregate generated cytoplasmic micronuclei at the next interphase. Our data also suggested that micronuclear entrapment eliminated the DMs or morphologically transformed them into giant DMs or homogeneously staining regions (HSRs). In this study, we obtained a model explaining the consequences of DMs after double-strand breakage in cancer cells. Because double-strand breakage is frequently involved in cancer therapy, the model suggests how it affects gene amplification.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  clustered regularly interspaced short palindromic repeats; extrachromosomal double minutes; gene amplification; homogeneously staining regions

Year:  2019        PMID: 31569279     DOI: 10.1002/gcc.22810

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  17 in total

Review 1.  Gene regulation on extrachromosomal DNA.

Authors:  King L Hung; Paul S Mischel; Howard Y Chang
Journal:  Nat Struct Mol Biol       Date:  2022-08-10       Impact factor: 18.361

Review 2.  Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.

Authors:  Imran Noorani; Paul S Mischel; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2022-09-21       Impact factor: 65.011

Review 3.  Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers.

Authors:  Mohsen Karami Fath; Nastaran Karimfar; Andarz Fazlollahpour Naghibi; Shahriyar Shafa; Melika Ghasemi Shiran; Mehran Ataei; Hossein Dehghanzadeh; Mohsen Nabi Afjadi; Tahereh Ghadiri; Zahra Payandeh; Vahideh Tarhriz
Journal:  Cancer Cell Int       Date:  2022-05-25       Impact factor: 6.429

Review 4.  Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.

Authors:  Zesheng Li; Bo Wang; Hao Liang; Lei Han
Journal:  Int J Biol Sci       Date:  2022-06-13       Impact factor: 10.750

Review 5.  The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.

Authors:  Eric van Leen; Lotte Brückner; Anton G Henssen
Journal:  Nat Genet       Date:  2022-02-10       Impact factor: 41.307

6.  Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges.

Authors:  Kai Song; Jenna K Minami; Arthur Huang; Siavash R Dehkordi; Shirley H Lomeli; Jens Luebeck; Mark H Goodman; Gatien Moriceau; Oscar Krijgsman; Prashanthi Dharanipragada; Trevor Ridgley; William P Crosson; Jesus Salazar; Eli Pazol; Gabriel Karin; Rachana Jayaraman; Nikolas G Balanis; Salwan Alhani; Kyle Sheu; Johanna Ten Hoeve; Amelia Palermo; Stephen E Motika; T Niroshi Senaratne; Kim H Paraiso; Paul J Hergenrother; P Nagesh Rao; Asha S Multani; Daniel S Peeper; Vineet Bafna; Roger S Lo; Thomas G Graeber
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

Review 7.  Extrachromosomal DNA: An Emerging Hallmark in Human Cancer.

Authors:  Sihan Wu; Vineet Bafna; Howard Y Chang; Paul S Mischel
Journal:  Annu Rev Pathol       Date:  2021-11-09       Impact factor: 32.350

8.  ecDNA hubs drive cooperative intermolecular oncogene expression.

Authors:  King L Hung; Kathryn E Yost; Liangqi Xie; Quanming Shi; Konstantin Helmsauer; Jens Luebeck; Robert Schöpflin; Joshua T Lange; Rocío Chamorro González; Natasha E Weiser; Celine Chen; Maria E Valieva; Ivy Tsz-Lo Wong; Sihan Wu; Siavash R Dehkordi; Connor V Duffy; Katerina Kraft; Jun Tang; Julia A Belk; John C Rose; M Ryan Corces; Jeffrey M Granja; Rui Li; Utkrisht Rajkumar; Jordan Friedlein; Anindya Bagchi; Ansuman T Satpathy; Robert Tjian; Stefan Mundlos; Vineet Bafna; Anton G Henssen; Paul S Mischel; Zhe Liu; Howard Y Chang
Journal:  Nature       Date:  2021-11-24       Impact factor: 69.504

9.  Oncogene Convergence in Extrachromosomal DNA Hubs.

Authors:  Natasha E Weiser; King L Hung; Howard Y Chang
Journal:  Cancer Discov       Date:  2022-05-02       Impact factor: 38.272

Review 10.  Cytokinesis-Block Micronucleus Cytome Assay Evolution into a More Comprehensive Method to Measure Chromosomal Instability.

Authors:  Michael Fenech
Journal:  Genes (Basel)       Date:  2020-10-15       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.